Neither anti-CHI3L1 nor chitin treatment affected hematogenous metastases to the lungs, but both treatment strategies equally and significantly decreased axillary lymph node metastases in 4T1 tumor-bearing mice (Fig. 10A), despite their differential effect on 4T1 primary tumor growth. This evidence concerns the gene CHI3L1 and neoplasm.